Emmilia Hodak, MD

Professor and Chair, Division of Dermatology, Rabin Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel.

Dr. Hodak obtained her MD from Tel Aviv University and completed specialization training at the Department of Dermatology of Rabin Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University. After earning  board certification in dermatology, Dr. Hodak was granted a one-year fellowship  in dermatopathology from New York University, NY, and served as a guest investigator for one year in the Laboratories for Investigative Dermatology, Rockefeller University, NY. On returning to Israel, she assumed a full-time position as a senior dermatologist in Rabin Medical Center, where she is today.

Dr. Hodak established the first Cutaneous Lymphoma Clinic in Israel. Thereafter she was appointed Director of the Skin Cancer Unit of the Department of Dermatology, and in 2011, Chair of the Division of Dermatology. Dr. Hodak has authored about 200 published articles. She has been invited to speak at many national and international meetings. Dr. Hodak has long had special interest in clinicopathological and translational research in cutaneous lymphoma. She and her colleagues defined new clinicopathological variants of mycosis fungoides, the most common type of cutaneous lymphoma, and contributed major diagnostic and therapeutic insights into mycosis fungoides in the pediatric age group. Dr. Hodak established the Laboratory for Investigative Dermatology at Felsenstein Medical Center, Tel Aviv University focusing on the genetic, epigenetic, and other molecular pathomechanisms of mycosis fungoides, including a search for new drugs.

Dr Hodak is actively involved in many national and international professional activities. She is the President of the Israel Society of Dermatology, Secretary of the International Society of Cutaneous Lymphoma, a member of the Steering Committee of the Cutaneous Lymphoma International Consortium (CLIC).